Comprehensive Psychiatry
Volume 47, Issue 4 , Pages 276-281 , July 2006

Clinical features associated with treatment response in obsessive-compulsive disorder

  • Roseli G. Shavitt

      Affiliations

    • Department of Psychiatry, University of São Paulo School of Medicine, Caixa Postal 8091, São Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da USP, Rua Dr. Ovídio Pires de Campos, s/n, 4°. andar-CEP 05430-010, São Paulo-SP-Brazil. Tel.: +55 11 30696972; fax: +55 11 30697895.
    • ,
  • Cristina Belotto

      Affiliations

    • Department of Psychiatry, University of São Paulo School of Medicine, Caixa Postal 8091, São Paulo, Brazil
    • ,
  • Mariana Curi

      Affiliations

    • Institute of Mathematics and Statistics, University of São Paulo, Caixa Postal 8091, São Paulo, Brazil
    • ,
  • Ana G. Hounie

      Affiliations

    • Department of Psychiatry, University of São Paulo School of Medicine, Caixa Postal 8091, São Paulo, Brazil
    • ,
  • Maria C. Rosário-Campos

      Affiliations

    • Department of Psychiatry, University of São Paulo School of Medicine, Caixa Postal 8091, São Paulo, Brazil
    • ,
  • Juliana B. Diniz

      Affiliations

    • Department of Psychiatry, University of São Paulo School of Medicine, Caixa Postal 8091, São Paulo, Brazil
    • ,
  • Ygor A. Ferrão

      Affiliations

    • Institute of Psychiatry and Mental Health of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Caixa Postal 8091, Brazil
    • ,
  • Michele T. Pato

      Affiliations

    • Center for Psychiatric and Molecular Genetics, State University of New York, Upstate Medical University, Syracuse, NY, USA
    • ,
  • Eurípedes C. Miguel

      Affiliations

    • Department of Psychiatry, University of São Paulo School of Medicine, Caixa Postal 8091, São Paulo, Brazil

References 

  1. Greist JH, Jefferson JW, Kobak KA, et al. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: a meta-analysis. Arch Gen Psychiatry. 1995;52:53–60
  2. Steketee G, Eisen J, Dyck I, et al. Predictors of course in obsessive-compulsive disorder. Psychiatry Res. 1999;89:229–238
  3. Mataix-Cols D, Rauch S, Manzo PA, et al. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 1999;156:1409–1416
  4. Saxena S, Maidment KM. Treatment of compulsive hoarding. J Clin Psychol. 2004;60(11):1143–1154
  5. Black DW, Monahan P, Gable J, et al. Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. J Clin Psychiatry. 1998;59:420–425
  6. Erzegovesi S, Cavallini MC, Cavedini P, et al. Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol. 2001;21:488–492
  7. Neziroglu FA, Pinto A, Yaryura-Tobias JA, et al. Overvalued ideation as a predictor of fluvoxamine response in patients with obsessive-compulsive disorder. Psychiatry Res. 2004;125:53–60
  8. Denys D, Burger H, van Megen H, de Geus F, Westenberg H. A score for predicting response to pharmacotherapy in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2003;18:315–322
  9. Miguel EC, Rosário-Campos MC, Prado HS, et al. Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry. 2000;61:150–156
  10. Eichsted JA, Arnold SL. Childhood-onset obsessive compulsive disorder: a tic-related subtype of OCD?. Clin Psychol Rev. 2000;21(1):137–158
  11. Rosário-Campos MC, Leckman JF, Mercadante MT, et al. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry. 2001;158:1899–1903
  12. Geller DA, Biederman J, Jones J, et al. Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. J Am Acad Child Adolesc Psychiatry. 1998;37(4):420–427
  13. McDougle CJ, Goodman WK, Leckman JF, et al. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994;51:302–308
  14. Leckman JF, Peterson BF, Pauls DL, et al. Tic disorders. Psychiatr Clin North Am. 1997;20(4):839–861
  15. Summerfeldt LJ. Understanding and treating incompleteness in obsessive-compulsive disorder. J Clin Psychol. 2004;60(11):1155–1168
  16. Leckman JF, Walker DE, Goodman WK, et al. “Just-right” perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry. 1994;151:675–680
  17. Miguel EC, Coffey BJ, Baer L, et al. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry. 1995;56:246–255
  18. Miguel EC, Baer L, Coffey BJ, et al. Phenomenological differences of repetitive behaviors in obsessive-compulsive disorder and Tourette's syndrome. Br J Psychiatry. 1997;170:140–145
  19. Diniz JB, Rosario-Campos MC, Shavitt RG, et al. Impact of age at onset and duration of illness on the expression of comorbidities in obsessive-compulsive disorder. J Clin Psychiatry. 2004;65(1):22–27
  20. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown obsessive compulsive scale: I. Development, use and reliability. Arch Gen Psychiatry. 1989;46:1006–1011
  21. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2. New York: New York State Psychiatric Institute, Biometrics Research; 1995;
  22. Pauls DL, Alsobrook JPII, Goodman W, et al. A family study of obsessive-compulsive disorder. Am J Psychiatry. 1995;152:76–84
  23. Rosário-Campos MC, Leckman JF, Curi M, Quatrano S, Katsovitch L, Miguel EC, et al. A family study of early-onset obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2005;136(1):92–97
  24. Leckman JF, Riddle MA, Hardin MT. The Yale global tic severity scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28:566–573
  25. Leckman JF, Sholomskas D, Thompson WD, et al. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry. 1982;39(8):879–883
  26. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571
  27. Beck AT, Brown G, Epstein N, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–897
  28. Piccinelli M, Pini S, Bellantuono C, et al. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Br J Psychiatry. 1995;166:424–433
  29. Ackerman DL, Greenland S. Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. J Clin Psychopharmacol. 2002;22:309–317
  30. Geller DA, Biederman J, Stewart SE, et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry. 2003;160:1919–1928
  31. Guy W. ECDEU assessment manual for psychopharmacology, revised. NIMHANS J. 1976;76(338):217–222
  32. Bienvenu OJ, Samuels JF, Riddle MA, et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry. 2000;48:287–293
  33. Scahill L, Chappell PB, Kim YS, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158:1067–1074
  34. Mc Dougle CJ, Goodman WK, Leckman JF, et al. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol. 1993;13:354–358
  35. Donahue DH, Meador M, Fortune T, et al. Tourette's syndrome and treatment with clomipramine hydrochloride. WV Med J. 1991;87(10):468–470
  36. Iancu I, Kotler M, Bleich A, et al. Clomipramine efficacy for Tourette syndrome and major depression: a case study. Biol Psychiatry. 1995;38:407–409
  37. Miguel EC, Shavitt RG, Ferrao YA, et al. How to treat OCD in patients with Tourette syndrome. J Psychosom Res. 2003;55(1):49–57
  38. Leckman JF, Riddle MA. Tourette's syndrome: when habit-forming systems form habits of their own?. Neuron. 2000;28:349–354
  39. Coffey BJ, Miguel EC, Savage CR, et al. Tourette's disorder and related problems: a review and update. Harv Rev Psychiatry. 1994;35:615–747
  40. Rasmussen SA, Eisen J. The epidemiology and clinical features of obsessive-compulsive disorder. In:  Jenike MA,  Baer L,  Minichiello WE editor. Obsessive-compulsive disorders—practical management. 3rd ed.. St. Louis (Mo): Mosby, Inc; 1998;p. 12–43

PII: S0010-440X(05)00107-0

doi: 10.1016/j.comppsych.2005.09.001

Comprehensive Psychiatry
Volume 47, Issue 4 , Pages 276-281 , July 2006

Article Tools